Eliminating the monitoring period with subcutaneous daratumumab: a single-center experience
- Resource Type
- article
- Source
- Blood Cancer Journal, Vol 13, Iss 1, Pp 1-3 (2023)
- Subject
Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 - Language
- English
- ISSN
- 2044-5385